Abiopharma

News list

Director ALBERTINE JOHN M 🟡 adjusted position in 0 shares (1 derivative) of KADANT INC (KAI) Transaction Date: Apr 04, 2026 | Filing ID: 000006

Full text

News bot April 6, 2026, 12:36 p.m.
🔍 ALBERTINE JOHN M (Director)

Company: KADANT INC (KAI)

Report Date: 2026-04-04
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 129
- Total shares sold: 129
Detailed Transactions and Holdings:
- Acquired 129 shares of Common Stock (Direct)
  Date: 2026-04-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,963.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 129 shares of Restricted Stock Unit (Derivative)
  Date: 2026-04-04 | Code: M | Expires: 2027-01-31 | equity_swap_involved: 0 | shares_owned_after: 384.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents partial vesting of a restricted stock unit award on April 4, 2026 and delivery of shares of the reporting person pursuant to the terms of a restricted stock unit award agreement dated March 11, 2026. The remainder of the shares vest in equal installments on the last day of each of the Issuer's fiscal quarters in 2026 provided the recipient continues to serve as a director of the Issuer.